Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05903469

Implicit and Explicit Assessment of Suicide Risk

In 2007 Nock & Banaji developed a so-called implicit suicide risk measurement using a computer tool: the Implicit Association Test (IAT). This measurement, associated with traditional evaluations, makes it possible to better predict suicidal recurrence. In 2020, the Poitiers team of Tello was able to replicate these results on a French population. However, although a high IAT score predicts the onset of suicide at 1 year, there is no data on how this score changes over time nor even data concerning the measure's ability to differentiate a population with explicit suicidal ideation from a population without explicit suicidal ideation. The investigators therefore seek to demonstrate an evolution of implicit suicidal ideation over time by replicating the measurement at inclusion, at 6 months and at 12 months, for different patient profiles: Suicidal ideation vs No suicidal ideation and suicide attempt vs no suicide attempt. Patients will be recruited from the emergency-unit of CHU Amiens-Picardie and will take the suicide-IAT as well as various questionnaires.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Centre Hospitalier Universitaire d'Amiens

Amiens, Picardie, 80000, France

Location status: Recruiting

Location contact

Jérôme Thilliez, MD

CONTACT

[email protected]

03.22.66.82.90

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Person presenting to emergencies for psychiatric reasons
  • Adult person
  • Free and informed consent signed
  • Person speaking and writing French fluently

Exclusion criteria

  • Neurological disorders or major cognitive deterioration: presence of confusion
  • Acute psychotic decompensation
  • Troubled acute behavior
  • Abuse Impregnation of a toxic substance and / or drug impairing cognitive functions at the time of assessment
  • Adult under protective measure.

Treatment and study plan

Implicit Attitude Test

Other

The IAT (Implicit Attitude Test) is a method of indirectly measuring the relative strength of associations between different concepts stored in memory based on reaction times on computer. The general idea behind this measure is that an individual will be much faster to categorize an object into a predetermined category, if this categorization is consistent with their own way of processing information.

Primary outcomes

  1. Variation of IAT score betwenn the 3 groups

    Time frame: one year

    IAT is Implicit Attitude Test The IAT is a brief computer-administered test that uses people's reaction times when classifying semantic stimuli to measure the automatic mental associations they hold about various topics, in this case, life and death/suicide. The death/suicide IAT will be administered and scored in keeping with standard IAT procedures. Response latencies for all trials were recorded and analyzed using the standard IAT scoring algorithm.

Study contacts

Contact information is provided by the study sponsor or research team.

Jérôme Thilliez, MD

CONTACT

[email protected]

03.22.66.82.90

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire, Amiens

Other

Collaborators

  • Centre Hospitalier Pinel d'Amiens

Registry information

Acronym: MIERIS

Important dates

Study start
2022
Primary completion
2025
Study completion
2026
First posted
Jun 15, 2023
Registry last updated
May 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.